	Innovations in Diagnosis Immunotherapy and Combination Therapy of Prostate Cancer: A Patent-driven Analysis. Recent Pat Anticancer Drug Discov Relan R, Sambar B, Dudam AK, Kanugo A. PMID: 42515880 [PubMed - as supplied by publisher]
	INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol. BJU Int Lister-Whelan R, Senior E, Kendall J, Oughton JB, Collinson F, Griffin J, Hubbard R, Kennish S, Noon A, Rosario DJ, Riaz IB, Telliez J, Catto JWF, Hussain SA. PMID: 42515859 [PubMed - as supplied by publisher]
	Preclinical Models of Bladder Cancer: Barrier, Metabolic, and Translational Susceptibility. Pharmaceuticals (Basel) Liu T, Li W, Yin Q, Liu D, Wang Y, Cui N. PMID: 42515797 [PubMed - as supplied by publisher]
	Feasibility and Acceptability of a Group-Based Telehealth Stress Management and Resilience Training Intervention for Men with Prostate Cancer on Active Surveillance. J Clin Med Mohamed NE, Noel JC, Scharp D, Fu W, Joshi H, Korn T, Johnson I, Tewari A, Gonzalez A. PMID: 42513453 [PubMed - as supplied by publisher]
	CT-Based Radiomics for Prediction of Molecular Markers in Clear Cell Renal Cell Carcinoma: A Comprehensive Review. Medicina (Kaunas) Boukali E, Koumpis P, Romeo E, Vartholomatos E, Alexiou GA, Argyropoulou MI, Tsili AC. PMID: 42512891 [PubMed - as supplied by publisher]
	Theranostic Potential of (177)Lu-TLX591 with Best Standard-of-Care and (68)Ga-PSMA-11 PET for Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the Phase 1 ProstACT SELECT Trial. Cancers (Basel) Lenzo N, O'Byrne K, Ngai S, Krieger L, Wong V, Cade DN. PMID: 42512394 [PubMed - as supplied by publisher]
	Low-Cost Pathology Signals for Risk Stratification in High-Risk Non-Muscle-Invasive Bladder Cancer: A Narrative Review. Cancers (Basel) Sala-González N, Chekhun S, Fina C, Vilaseca M, Rossylna O, Boix R, Bella-Burgos B, Comet J. PMID: 42512334 [PubMed - as supplied by publisher]
	Robot-Assisted Versus Open Nephrectomy with Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma: Current Evidence and Surgical Trends. Cancers (Basel) Korbecka Z, Jab, Król R. PMID: 42512316 [PubMed - as supplied by publisher]
	Early Post-Treatment Eosinophil Elevation and Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with First-Line VEGFR-TKI Monotherapy: A Turkish Multicenter Retrospective Cohort Study. Biomedicines Aktepe OH, Rustamov S, Izgor RB, Butun O, Karakaya S, Ulasli T, Yalcin S. PMID: 42512093 [PubMed - as supplied by publisher]
	Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls. Int J Mol Sci Sokólska W, Zajkowska M, Nowi, Orywal K. PMID: 42511541 [PubMed - as supplied by publisher]
	A Network Pharmacology Review of Plant-Derived Anticancer Compounds in Lung, Breast, Colorectal and Prostate Cancer. Int J Mol Sci Merecz-Sadowska A, Sadowski A, Zajdel K, J, Sitarek P, Zajdel R. PMID: 42511521 [PubMed - as supplied by publisher]
	The Oncogenic Role of Prostate Stem Cell Antigen (PSCA) in Colorectal Cancer: Implications for Targeted Therapy. Curr Issues Mol Biol Duan J, Wang Y, Li Q, Wang Y, Liu J, Qi Y, Zhang Y, Fu C, Cong Z, Wang C, Su M. PMID: 42510977 [PubMed - as supplied by publisher]
	SnoRNA and SNHG in Bladder Cancer: Molecular Mechanisms and Clinical Significance. Curr Issues Mol Biol Gimalova G, Gilyazova I, Khusnutdinova E, Pavlov V. PMID: 42510903 [PubMed - as supplied by publisher]
	Recent Advances in Multimodal Assessment Scoring Systems for Prostate Cancer: An Integrated Pathological and Imaging Perspective. Diagnostics (Basel) Zhang X, Wang C. PMID: 42510039 [PubMed - as supplied by publisher]
	Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial. Lancet Oncol Tyson MD 2nd, Nam JK, Joshi SS, Uchio EM, Jung SI, Bivalacqua TJ, Steinberg GD, Shore ND, Burke JM, Kitamura H, Tran B, Li R. PMID: 42508433 [PubMed - indexed for MEDLINE]
	Contemporary Trends in the Surgical and Systemic Management of Muscle-Invasive Bladder Cancer: Insights From a Nationwide Multicenter Cohort in Turkey Over 2 Decades. Clin Genitourin Cancer Akpinar C, Aydo, Sahin B, Gül, Akgül HM, Y, Suer E, Cetin S, Aslan G, Turkeri L, Aydemir S, Ozden E, Bilen CY. PMID: 42508290 [PubMed - as supplied by publisher]
	Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801). J Clin Oncol McKay RR, Ballman KV, Atherton PJ, Ajmera A, Al Baghdadi T, Baumann BC, Beltran H, Berg S, Chen RC, Choudhury AD, Cole S, Jacene HA, Lang JM, Kilari D, Kwok Y, McGregor B, Morris MJ, Parikh M, Swami U, Tan A, Yang YA, Zhang T, Galsky M, Rosenberg J, George D, Choueiri TK. PMID: 42507969 [PubMed - as supplied by publisher]
	Development and Internal Validation of a Prediction Model For Biochemical Recurrence Following Radical Prostatectomy. J Vis Exp Li Y, Zhang Q, Li X. PMID: 42507709 [PubMed - indexed for MEDLINE]
	Urinary and cellular volatile organic compounds as biomarkers for urological cancers: a systematic review of GC-MS-based volatolomics. Metabolomics Xie B, Wen Q. PMID: 42507083 [PubMed - indexed for MEDLINE]
	Inter-Vendor Variability of Perfusion Parameters Derived from Dynamic Contrast-Enhanced MRI in Patients with Prostate Cancer. Tomography Kim M, Kim SH, Kim JY. PMID: 42506856 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180333

Page 1 of 9017



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy